ThermoGenesis Sees Explosive Growth Opportunities in Stem Cells

Mel Engle, CEO of ThermoGenesis [NASDAQ: KOOL] recently discussed with OneMedRadio, the company’s stem cell products and FDA approval that may have groundbreaking implications for the stem cell market.

Read more »

ThermoGenesis to Begin Sale of Novel Stem Cell Device in India

ThermoGenesis said its device, used in processing stem cells from bone marrow, got Indian marketing approval, sending its shares up as much as 8 percent.

Read more »